ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Amgen Web Site For Patients Goes Dark After Story In The Cancer Letter.

November 16, 2007

In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise

October 14, 1988

Doctor Files Defamation Suit Against Former Patient, But Legal Action Triggers Adverse Events

April 20, 2012

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

60 Minutes To Air Segment On The “Deception at Duke”

February 10, 2012

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014